Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Invesco
Atlanta,
Georgia
| $788M | -$103M | 23 | 0.24% | Reduced |
|
| 27 |
JP Morgan Chase
New York
| $768M | +$99M | 49 | 0.14% | Increased |
|
| 28 |
Goldman Sachs
New York
| $689M | +$75.5M | 43 | 0.18% | Increased |
|
| 29 |
Geode Capital Management
Boston,
Massachusetts
| $615M | +$25.9M | 61 | 0.13% | Increased |
|
| 30 |
OrbiMed
New York
| $611M | +$128K | 17 | 8.72% | Increased |
|
| 31 |
Bank of New York Mellon
New York
| $589M | -$10.5M | 47 | 0.15% | Reduced |
|
| 32 |
Capital International Investors
Los Angeles,
California
| $587M | -$314M | 9 | 0.2% | Reduced |
|
| 33 |
Perceptive Advisors
New York
| $583M | -$61M | 10 | 11.58% | Reduced |
|
| 34 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $572M | +$4.17M | 1 | 4.63% | Increased |
|
| 35 |
Morgan Stanley
New York
| $557M | +$72.9M | 62 | 0.13% | Increased |
|
| 36 |
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
| $551M | $0 | 1 | 8.13% | Maintained |
|
| 37 |
Aristotle Capital Management
Los Angeles,
California
| $548M | +$204M | 1 | 1.8% | Increased |
|
| 38 |
Dimensional Fund Advisors
Austin,
Texas
| $541M | +$7.66M | 32 | 0.2% | Increased |
|
| 39 |
Ameriprise
Minneapolis,
Minnesota
| $534M | +$36M | 22 | 0.22% | Increased |
|
| 40 |
Avoro Capital Advisors
New York
| $519M | +$55.6M | 5 | 15.24% | Increased |
|
| 41 |
Citadel Advisors
Miami,
Florida
| $497M | +$46.5M | 44 | 0.22% | Increased |
|
| 42 |
Norges Bank
Oslo,
Norway
| $456M | +$19.2M | 19 | 0.13% | Increased |
|
| 43 |
Jennison Associates
New York
| $443M | +$147M | 4 | 0.45% | Increased |
|
| 44 |
Arrowstreet Capital
Boston,
Massachusetts
| $423M | +$102M | 12 | 0.98% | Increased |
|
| 45 |
TS
Third Security
Radford,
Virginia
| $420M | +$2.99M | 2 | 67.82% | Increased |
|
| 46 |
Brown Brothers Harriman & Co
New York
| $417M | -$32.1M | 4 | 2.67% | Reduced |
|
| 47 |
Charles Schwab Investment Advisory
San Francisco,
California
| $417M | +$8.68M | 1 | 0.59% | Increased |
|
| 48 |
Nikko Asset Management Americas
New York
| $401M | +$19.9M | 10 | 6.32% | Increased |
|
| 49 |
Adage Capital Partners
Boston,
Massachusetts
| $380M | +$9.85M | 14 | 0.93% | Increased |
|
| 50 |
Charles Schwab
San Francisco,
California
| $375M | +$19.4M | 41 | 0.2% | Increased |
|